REGENERATE Clinical Study
Ever been told you have elevated liver enzymes or fatty liver?
You may be eligible to participate in a research study for NASH and receive study-related medical care at no charge.
What is NASH?
Nonalcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease. It is caused by excess fat in the liver that leads to inflammation and tissue injury.
What are risk factors for NASH?
People with type 2 diabetes, obesity, high cholesterol, insulin resistance, and high blood pressure may have NASH.
The REGENERATE Study will evaluate the effects of obeticholic acid (OCA) on improvement in nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease. Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver.
Learn more about the REGENERATE Study at https://nash-study.com/the-regenerate-study.
Is this Research Study for You?
Subjects should be at least 18 years of age with a diagnosis of NASH and have some evidence of fibrosis.
How the Study Works
Drexel University College of Medicine is conducting a research study to evaluate an investigational drug for NASH.
- Study participation is up to six 6 years
- Eligible participants receive study-related medical evaluations and the investigational drug at no charge
- Reimbursement for travel and meal expenses may be provided
Location of the Research Study
Center for Liver, Biliary and Pancreatic Diseases
216 N. Broad Street, 15th Floor
Philadelphia, PA 19102
* Physician's practice/location is independent of Drexel Medicine and Drexel University.
The information on these pages is provided for general information only and should not be used for diagnosis or treatment, or as a substitute for consultation with a physician or health care professional. If you have specific questions or concerns about your health, you should consult your health care professional.
The images being used are for illustrative purposes only; any person depicted is a model.
Back to Top